These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7792886)

  • 21. Pathogenetic studies in a rat cardiac model of chronic vascular rejection.
    Forbes RD; Zheng SX; Gomersall M; al-Saffar M; Prud'homme GJ; Guttmann RD
    Transplant Proc; 1995 Jun; 27(3):2080. PubMed ID: 7792892
    [No Abstract]   [Full Text] [Related]  

  • 22. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
    Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
    J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferation of smooth muscle cells in acute allograft vascular rejection.
    Amano J; Ishiyama S; Nishikawa T; Tanaka H; Nagai R; Marumo F; Hiroe M
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):19-25. PubMed ID: 9011689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    El-Hamamsy I; Stevens LM; Vanhoutte PM; Perrault LP
    J Heart Lung Transplant; 2005 Mar; 24(3):251-8. PubMed ID: 15737750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia.
    Aziz S; McDonald TO; Gohra H
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic changes in a long-term heterotopic heart transplant survivor.
    Pucci A; Passarino G; Marra S; Papandrea C; Casaccia M; di Summa M; Mollo F
    Cardiologia; 1995 Jun; 40(6):427-30. PubMed ID: 8640856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are neointimal smooth muscle cells in human cardiac allograft vasculopathy of donor origin?
    Beranek JT
    J Heart Lung Transplant; 2005 Aug; 24(8):1121-2. PubMed ID: 16102451
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac allograft vasculopathy: current concepts.
    Ventura HO; Smart FW; Stapleton DD; Toups T; Price HL
    J La State Med Soc; 1993 May; 145(5):195-8, 200-2. PubMed ID: 8393471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of acute rejection on the endothelium-dependent relaxation of coronary arteries of the transplanted heart in dogs].
    Bouchard D; Cartier R; Despatis MA; Carrier M; Leung TK
    Ann Chir; 1995; 49(8):735-42. PubMed ID: 8561429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Directional coronary atherectomy in heart transplant recipients.
    Jain SP; Ventura HO; Ramee SR; Collins TJ; Isner JM; White CJ
    J Heart Lung Transplant; 1993; 12(5):819-23. PubMed ID: 8241222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the morphology and components of the coronary arteries during the progression of coronary arteriosclerosis following cardiac transplantation in rats.
    Hamano K; Ito H; Fujimura Y; Tsuboi H; Esato K
    Cardiovasc Surg; 1998 Jun; 6(3):296-301. PubMed ID: 9705103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation.
    Jennison SH; Wesp AG; McBride LR; Miller LW
    Transplant Proc; 1994 Oct; 26(5):2732-5. PubMed ID: 7940857
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrogen and prevention of transplant atherosclerosis.
    Foegh ML; Zhao Y; Lou H; Katz NM; Ramwell PW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S170-2. PubMed ID: 8719480
    [No Abstract]   [Full Text] [Related]  

  • 37. Morphology of graft arteriosclerosis in cardiac transplant recipients.
    Liu G; Butany J
    Hum Pathol; 1992 Jul; 23(7):768-73. PubMed ID: 1612576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
    Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
    Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.